Atherosclerosis and its complications are the leading cause of death in the United States. This process, by which arteries become narrowed and eventually occluded, is still not clearly understood, but current concepts suggest that the serum lipoproteins, especially low density lipoprotein (LDL), play an important role. Evidence is accumulating that indicates that modifications of LDL, particularly oxidation, may play a critical role in the initiation of atherosclerotic plaque formation. A receptor on the surface of macrophages, called the acetyl-LDL or scavenger receptor, appears to be responsible for the uptake of modified lipoproteins and the subsequent conversion of macrophages to cholesterol-loaded foam cells. An understanding of the process of foam cell formation is critical to any understanding of atherosclerosis, since the foam cell is one of the earliest changes noted in the development of an atherosclerotic plaque. The expression of scavenger receptors on macrophages and smooth muscle cells appears to be regulated. Differentiation of the monocyte into a macrophage is associated with a dramatic increase in receptor activity and recent evidence suggests that several cytokines can induce a substantial increase in smooth muscle cell scavenger receptors. The research proposed in this grant is intended to identify the molecular genetic signals that control scavenger receptor expression in both macrophages and smooth muscle cells. Gene constructs encoding various fragments of the control regions in the scavenger receptor's promoter will be linked to a reporter gene will be made. These constructs will then be transfected into macrophages, smooth muscle cells, and non-vascular cell types in order to determine the specificity of control elements. Once this process has been well characterized, similar gene constructs will be injected into transgenic mice in order to confirm, in vivo, the observations that have been made in vitro. With this accomplished, it should then be possible to study foam cell formation in the transgenic animal by feeding a high fat/high cholesterol diet. Using native and mutated transgene constructs, it is anticipated that these studies will lead to new insights into the process of atherosclerotic plaque development and the role that scavenger receptors play in that process. This information has the potential to open up new therapeutic avenues whose exploration could lead to advances in the prevention of coronary heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL045098-07
Application #
2415570
Study Section
Metabolism Study Section (MET)
Project Start
1990-07-01
Project End
1999-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
7
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Manning-Tobin, Jennifer J; Moore, Kathryn J; Seimon, Tracie A et al. (2009) Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol 29:19-26
Moore, Kathryn J; Freeman, Mason W (2008) Targeting Innate Immunity for CV Benefit. Drug Discov Today Ther Strateg 5:15-23
Fitzgerald, Michael L; Xavier, Ramnik; Haley, Kathleen J et al. (2007) ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J Lipid Res 48:621-32
Moore, Kathryn J; Kunjathoor, Vidya V; Koehn, Stephanie L et al. (2005) Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 115:2192-201
Kim, Woojin Scott; Fitzgerald, Michael L; Kang, Kihwa et al. (2005) Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J Biol Chem 280:3989-95
Okuhira, Kei-ichiro; Fitzgerald, Michael L; Sarracino, David A et al. (2005) Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux. J Biol Chem 280:39653-64
Bjorkbacka, Harry; Kunjathoor, Vidya V; Moore, Kathryn J et al. (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10:416-21
Bjorkbacka, Harry; Fitzgerald, Katherine A; Huet, Francois et al. (2004) The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol Genomics 19:319-30
Fitzgerald, Michael L; Okuhira, Kei-Ichiro; Short 3rd, Glenn F et al. (2004) ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities. J Biol Chem 279:48477-85
El Khoury, Joseph B; Moore, Kathryn J; Means, Terry K et al. (2003) CD36 mediates the innate host response to beta-amyloid. J Exp Med 197:1657-66

Showing the most recent 10 out of 32 publications